Are you an innovative start-up, or a researcher with compelling new data? Would you like to present your company or latest scientific findings at the leading microbiome-focused event? If so, we would like to hear from you!
After its sell-out 2019 edition in Copenhagen, Probiota will be heading to Dublin in February 2020. Check out the key themes and outline agenda for the leading probiotic, prebiotic and microbiome event … and register now for the three-day festival of...
An expert panel has identified that interventions based on biomarkers and disease prevention need to be the key priority areas for the nutritional scientific community to promote healthy ageing as the number of seniors in APAC soars.
Global omega-3 player KD Pharma says the new site at Seal Sands will expand its capacity for manufacturing omega-3-based intermediates, especially for those use in producing active pharmaceutical ingredients (APIs).
With ever-blurring lines between the food and pharmaceutical space, the NutraIngredients team asked experts at our recent Probiota conference how they believe the microbiome space will develop in the future.
A combination of regulatory hurdles and growing consumer demand for more effective products means companies are looking for new ways to innovate with encapsulation technologies and delivery systems, say experts speaking to NutraIngredients.
While there has been an explosion in interest over colloidal delivery systems in recent years there has also been disconnect between primary research and commercialisation, says one expert who believes a novel ‘delivery by design’ approach could speed...
Nutrition solutions for critically ill patients should not ignore the potential of modulating gut bacteria for health, say researchers who suggest current enteral feeding solutions do not support gut defences and the microbiome.
Medical nutrition terminology is not consistently defined - with frequent inconsistencies between definitions and regulations relating to specific terms and practices, warn researchers who argue that standardised terminology is needed.
Bacteria in our guts may be impacting human health and disease by telling host genes what to do, say researchers who have uncovered a new mechanism by which our microbiome communicates with and controls the DNA of our own cells.